METFORAL

This brand name is authorized in Cyprus, Estonia, Hong Kong SAR China, Italy, Lithuania, Malta, Singapore, South Africa, Tunisia.

Active ingredients

The drug METFORAL contains one active pharmaceutical ingredient (API):

1	Metformin UNII 786Z46389E - METFORMIN HYDROCHLORIDE
	Metformin is a biguanide with antihyperglycaemic effects, lowering both basal and postprandial plasma glucose. It does not stimulate insulin secretion and therefore does not produce hypoglycaemia.
	Read more about Metformin

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
METFORAL Film-coated tablet	MPI, EU: SmPC	Υπουργείο Υγείας (CY)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
A10BA02	Metformin	A Alimentary tract and metabolism → A10 Drugs used in diabetes → A10B Blood glucose lowering drugs, excl. insulins → A10BA Biguanides
Discover more medicines within A10BA02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
EE	Ravimiamet	1011317, 1011328, 1064708, 1064719, 1064720, 1064731, 1164765, 1164776, 1164787, 1164798, 1462979, 1462980, 1757189, 1757190, 1757202, 1757213, 1757224, 1757279, 1757280, 1757291, 1757303, 1757314, 1757347, 1757358, 1757369, 1757370, 1757381, 1822889
HK	Department of Health Drug Office	52429, 52809
IT	Agenzia del Farmaco	019449014, 019449038, 037062039
LT	Valstybinė vaistų kontrolės tarnyba	1003374, 1003375, 1004021, 1004022, 1004330, 1010745, 1010746, 1017707, 1017708, 1017709, 1017710, 1064512
MT	Medicines Authority	AA203/00201, AA203/00202
SG	Health Sciences Authority	11527P
TN	Direction de la Pharmacie et du Médicament	9163141, 9163144
ZA	Health Products Regulatory Authority	34/21.2/0359, 34/21.2/0360